Mots-C (10mg/vial)

MOTS-c is a naturally occurring mitochondrial-derived peptide that has attracted significant scientific interest for its potential role in cellular energy production, metabolic health, and healthy aging. Unlike most peptides, MOTS-c is encoded by mitochondrial DNA and functions as a signaling molecule that helps cells adapt to metabolic stress.

Preclinical research suggests that MOTS-c activates key metabolic pathways involved in glucose utilization, insulin sensitivity, fat oxidation, and mitochondrial function. It has also been investigated for its potential to support exercise performance, recovery, and metabolic resilience by enhancing the body's ability to respond to energetic demands. While these findings are promising, the majority of evidence comes from laboratory and animal studies, and its effects in humans remain under investigation.

MOTS-c is currently an investigational peptide and has not been approved by Health Canada or the U.S. FDA for general clinical use. Human clinical research is ongoing to better understand its safety, effectiveness, and potential therapeutic applications in metabolic health and age-related conditions.